Ligand validation:6QL1

V50: 4-[(4,6-dimethylpyrimidin-2-yl)thio]-2,3,5,6-tetrafluorobenzenesulfonamide

V50 is a Ligand Of Interest in 6QL1 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6QL1_V50_A_305	69%	25%	0.137	0.951	1.14	1.88	2	10	0	0	100%	0.6522
6QL1_V50_A_306	16%	16%	0.297	0.872	1.35	2.35	3	12	2	0	100%	1
6YHB_V50_A_302	77%	21%	0.122	0.963	1.33	1.95	4	10	0	0	100%	1
7NZW_V50_A_302	70%	9%	0.145	0.962	1.67	2.81	5	18	0	0	100%	0.5
4HT0_V50_A_304	29%	1%	0.246	0.906	2.06	5.61	10	24	5	0	100%	1
4HT2_V50_D_302	95%	31%	0.076	0.982	1.13	1.61	1	7	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.